We are live on ! Find out more
Grantham, Mayo, Van Otterloo & Co (GMO)

Grantham, Mayo, Van Otterloo & Co (GMO) Portfolio holdings

AUM $39.1B
1-Year Est. Return 28.69%
This Fund
S&P 500
This Quarter Est. Return
+9.47%
1 Year Est. Return
+28.69%
3 Year Est. Return
+71.15%
5 Year Est. Return
+97.93%
10 Year Est. Return
+429.41%
AUM
$41.2B
AUM Growth
+$3.27B
Cap. Flow
-$186M
Cap. Flow %
-0.45%
Top 10 Hldgs %
40.32%
Holding
737
New
74
Increased
253
Reduced
310
Closed
75

Top Buys

Rank Stock Value
1
IBM icon
IBM
IBM
+$247M
2
XOM icon
ExxonMobil
XOM
+$200M
3
RTX icon
RTX Corp
RTX
+$193M
4
CVX icon
Chevron
CVX
+$182M
5
QCOM icon
Qualcomm
QCOM
+$166M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$642M
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$349M
3
MSFT icon
Microsoft
MSFT
+$204M
4
MCD icon
McDonald's
MCD
+$183M
5
MRK icon
Merck
MRK
+$174M

Sector Composition

Rank Sector Weight
1 Technology 23.1%
2 Healthcare 22.91%
3 Consumer Staples 22.12%
4 Energy 7.11%
5 Communication Services 6.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GOOG icon
1
Alphabet (Google) Class C
GOOG
$3.88T
$1.93B 4.69%
69,223,337
-13,786,282
-17% -$349M
MSFT icon
2
Microsoft
MSFT
$2.83T
$1.86B 4.51%
49,690,399
-5,605,586
-10% -$204M
ORCL icon
3
Oracle
ORCL
$346B
$1.83B 4.45%
47,906,184
-1,535,787
-3% -$52.8M
JNJ icon
4
Johnson & Johnson
JNJ
$624B
$1.81B 4.4%
19,775,624
-1,434,621
-7% -$132M
CVX icon
5
Chevron
CVX
$387B
$1.7B 4.12%
13,580,378
+1,507,602
+12% +$182M
IBM icon
6
IBM
IBM
$194B
$1.69B 4.1%
9,413,932
+1,431,051
+18% +$247M
KO icon
7
Coca-Cola
KO
$349B
$1.59B 3.85%
38,425,687
-1,973,083
-5% -$77.8M
PG icon
8
Procter & Gamble
PG
$342B
$1.59B 3.85%
19,470,736
+55,763
+0.3% +$4.54M
PM icon
9
Philip Morris
PM
$298B
$1.49B 3.61%
17,066,193
+855,976
+5% +$74.8M
WMT icon
10
Walmart Inc
WMT
$863B
$1.14B 2.75%
43,276,668
-2,734,554
-6% -$70.6M
CSCO icon
11
Cisco
CSCO
$444B
$1.08B 2.63%
48,184,364
+6,567,159
+16% +$145M
PEP icon
12
PepsiCo
PEP
$184B
$1.01B 2.46%
12,232,738
-1,320,764
-10% -$110M
ESRX
13
DELISTED
Express Scripts Holding Company
ESRX
$970M 2.35%
13,804,543
-286,597
-2% -$18.7M
PFE icon
14
Pfizer
PFE
$143B
$821M 1.99%
28,251,235
-22,052,086
-44% -$642M
MMM icon
15
3M
MMM
$87.5B
$778M 1.89%
6,638,189
+396,966
+6% +$42.3M
XOM icon
16
ExxonMobil
XOM
$650B
$771M 1.87%
7,621,912
+2,162,025
+40% +$200M
QCOM icon
17
Qualcomm
QCOM
$180B
$718M 1.74%
9,674,985
+2,352,731
+32% +$166M
AAPL icon
18
Apple
AAPL
$4.72T
$679M 1.65%
33,878,852
+6,250,160
+23% +$118M
CL icon
19
Colgate-Palmolive
CL
$72.1B
$672M 1.63%
10,304,826
-769,610
-7% -$49.3M
ABT icon
20
Abbott
ABT
$175B
$619M 1.5%
16,154,651
+124,422
+0.8% +$4.59M
MDT icon
21
Medtronic
MDT
$105B
$585M 1.42%
10,186,365
+62,283
+0.6% +$3.53M
UNH icon
22
UnitedHealth
UNH
$385B
$577M 1.4%
7,664,565
+1,055,162
+16% +$75.8M
MCD icon
23
McDonald's
MCD
$187B
$569M 1.38%
5,860,005
-1,902,906
-25% -$183M
MRK icon
24
Merck
MRK
$322B
$484M 1.17%
10,129,272
-3,799,809
-27% -$174M
BMY icon
25
Bristol-Myers Squibb
BMY
$126B
$475M 1.15%
8,939,857
+570,925
+7% +$29.1M
1
2 3 4 5

Similar funds

Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
Nomura Asset Management
Nomura Asset Management Tokyo, Japan $38.8B AUM 30.94% 1-Year Est. Return
Parallax Volatility Advisers
Parallax Volatility Advisers San Francisco, California $38.6B AUM 45.89% 1-Year Est. Return
Empower Advisory Group
Empower Advisory Group Greenwood Village, Colorado $38.5B AUM 18.4% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $39.9B AUM 29.7% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Credit Agricole
Credit Agricole Montrouge Cedex, France $38.1B AUM

Grantham, Mayo, Van Otterloo & Co (GMO)'s Q4 2013 Portfolio in Review

As of Q4 2013, Grantham, Mayo, Van Otterloo & Co (GMO) held 737 positions worth $41.2B, up 8.6% from $37.9B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Grantham, Mayo, Van Otterloo & Co (GMO)'s Q4 2013 filing shows 74 new, 253 increased, 310 reduced and 75 closed positions. Its largest new stake was ICICI Bank: 3,782,900 shares worth $25.6M. The largest sale was Pfizer, an estimated $642M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Consumer Staples.

  • Grantham, Mayo, Van Otterloo & Co (GMO)'s largest Q4 2013 buy was ICICI Bank: 3,782,900 shares worth $25.6M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) added most to IBM in Q4 2013, an estimated $247M increase.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s biggest Q4 2013 reduction was Pfizer, cutting an estimated $642M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) fully exited Vodafone in Q4 2013, selling an estimated $33.6M.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s ten largest holdings make up 40% of its $41.2B portfolio in Q4 2013.
  • Grantham, Mayo, Van Otterloo & Co (GMO) opened 74 new positions and closed 75 in Q4 2013.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio value rose 8.6% quarter-over-quarter to $41.2B.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q4 2013, filed 13 Feb 2014.